Alessandrino, Francesco <br/><br/>
Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.  [electronic resource] 

 -  Abdominal radiology (New York)  05 2019 
 - 1917-1927 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2366-0058 
<br/><br/><label>Standard No.: </label>10.1007/s00261-019-01935-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Biliary Tract Diseases--chemically induced<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Fluorodeoxyglucose F18<br/>Gastrointestinal Diseases--chemically induced<br/>Humans<br/>Immunotherapy--adverse effects<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Nivolumab--adverse effects<br/>Positron Emission Tomography Computed Tomography<br/>Radiography, Abdominal<br/>Radiopharmaceuticals<br/>Retrospective Studies<br/>Tomography, X-Ray Computed